Metabolism, metabolites, and macrophages in cancer

M Li, Y Yang, L Xiong, P Jiang, J Wang, C Li - Journal of hematology & …, 2023 - Springer
Tumour-associated macrophages (TAMs) are crucial components of the tumour
microenvironment and play a significant role in tumour development and drug resistance by …

Progress and prospect of immunotherapy for triple-negative breast cancer

C Luo, P Wang, S He, J Zhu, Y Shi, J Wang - Frontiers in Oncology, 2022 - frontiersin.org
Breast cancer is the most commonly diagnosed cancer (estimated 2.3 million new cases in
2020) and the leading cause of cancer death (estimated 685,000 deaths in 2020) in women …

d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma

S Han, X Bao, Y Zou, L Wang, Y Li, L Yang, A Liao… - Science …, 2023 - science.org
The polarization of tumor-associated macrophages (TAMs) from M2 to M1 phenotype
demonstrates great potential for remodeling the immunosuppressive tumor …

Recent advances of tubulin inhibitors targeting the colchicine binding site for cancer therapy

M Hawash - Biomolecules, 2022 - mdpi.com
Cancer accounts for numerous deaths each year, and it is one of the most common causes
of death worldwide, despite many breakthroughs in the discovery of novel anticancer …

An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma

B Xu, L Tian, J Chen, J Wang, R Ma, W Dong… - Nature …, 2021 - nature.com
Oncolytic herpes simplex virus-1 is capable of lysing tumor cells while alerting the immune
system. CD47, in collaboration with SIRPα, represents an important immune checkpoint to …

Immunological conversion of solid tumours using a bispecific nanobioconjugate for cancer immunotherapy

Y Lu, K Huntoon, DY Lee, Y Wang, JH Ha, Y Qie… - Nature …, 2022 - nature.com
Solid tumours display a limited response to immunotherapies. By contrast, haematological
malignancies exhibit significantly higher response rates to immunotherapies as compared …

Promoting antibody-dependent cellular phagocytosis for effective macrophage-based cancer immunotherapy

X Cao, J Chen, B Li, J Dang, W Zhang, X Zhong… - Science …, 2022 - science.org
Macrophages are essential in eliciting antibody-dependent cellular phagocytosis (ADCP) of
cancer cells. However, a satisfactory anticancer efficacy of ADCP is contingent on early …

[HTML][HTML] Macrophage-related therapeutic strategies: Regulation of phenotypic switching and construction of drug delivery systems

X Wang, Y Li, X Pu, G Liu, H Qin, W Wan, Y Wang… - Pharmacological …, 2024 - Elsevier
Macrophages, as highly phenotypic plastic immune cells, play diverse roles in different
pathological conditions. Changing and controlling the phenotypes of macrophages is …

TRAF3/STAT6 axis regulates macrophage polarization and tumor progression

JH Shi, LN Liu, DD Song, WW Liu, C Ling… - Cell Death & …, 2023 - nature.com
Converting tumor-associated macrophages (TAMs) from the M2 to the M1 phenotype is
considered an effective strategy for cancer therapy. TRAF3 is known to regulate NF-κB …

The CD47-SIRPα axis is a promising target for cancer immunotherapies

Y Hao, X Zhou, Y Li, B Li, L Cheng - International Immunopharmacology, 2023 - Elsevier
Abstract Cluster of differentiation 47 (CD47) is a transmembrane protein that is ubiquitously
found on the surface of many cells in the body and uniquely overexpressed by both solid …